Buy this ASX 200 gold share trading 'at a significant discount to peers'

While the gold price has come under pressure in recent weeks, most analysts agree that the precious metal will stay …

| More on:
A woman in a business suit sits at her desk with gold bars in each hand while she kisses one bar with her eyes closed. Her desk has another three gold bars stacked in front of her. symbolising the rising Northern Star share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While the gold price has come under pressure in recent weeks, most analysts agree that the precious metal will stay at lofty levels for some time to come.

In light of this, it could be a good idea to have some exposure to gold in your portfolio.

But which ASX 200 gold share could be in the buy zone now? Let's take a look at one that Goldman Sachs is bullish on and is tipping as a buy.

Which ASX 200 gold share?

The gold miner that Goldman is bullish on is Gold Road Resources Ltd (ASX: GOR).

Its shares rocketed on Monday after De Grey Mining Limited (ASX: DEG) agreed to be acquired by Northern Star Resources Ltd (ASX: NST) in a $5 billion deal.

Given that Gold Road owns a ~17% stake in De Grey Mining, it stands to benefit from this transaction and any potential competing offers.

In response to the news, Goldman said:

If the NST-DEG transaction completes (or attracts further competing proposals) we would see this as a positive for Gold Road Resources which own ~17.3% of DEG, with the implied acquisition price above our prior proportional NAV and potentially adding ~A$0.8bn to GOR's already net cash balance sheet (at current valuations should GOR sell their DEG stake or resulting NST shares where NST/DEG noted that GOR have historically been supportive of DEG, and that they are aware of the transaction with a decision to support the proposed acquisition up to GOR).

It also feels that this news could be the catalyst for a re-rating for the ASX 200 gold share, which it notes trades at a discount to peers. It said:

We note GOR also hold neighbouring leases to Hemi which may become attractive future development options at the project. Furthermore, with the possible sale of the DEG stake, we see potential support for GOR to re-rate on its own fundamentals, with the stock currently trading at a significant discount to peers at (~3.5x EV/EBITDA, ~1x NAV, and ~US$1,870/oz LT gold; peer average 5.7x/1.2x/~US$2,130/oz respectively), where closing half this gap would add >10-20% to valuation.

Time to buy

According to the note, the broker has retained its buy rating on the ASX 200 gold share with an improved price target of $2.35.

Based on its current share price of $2.04, this implies potential upside of over 15% for investors over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Bellevue, BHP, Brainchip, and Peninsula Energy shares are tumbling today

These shares are starting the week in the red. But why?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Block, DroneShield, EBR Systems, and Insignia shares are racing higher

These shares are starting the week on a high. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which All Ords ASX healthcare stock just surged 11% on FDA news

Investors are sending the ASX healthcare stock soaring on Monday.

Read more »

a man sits on a rocket propelled office chair and flies high above a city
Technology Shares

DroneShield share price rockets 9% on 'significant' new contract

ASX investors are sending the DroneShield share price flying higher on Monday.

Read more »

Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

Man drawing illustration of a big fish eating a little fish representing a takeover or acquisition.
Mergers & Acquisitions

ASX 200 stock jumps 11% on fresh takeover offer

Is a bidding war about to start for this financial services company?

Read more »

Opinions

Why I think these 2 bargain ASX 300 shares are buys

2025 could be a good year for these stocks, here’s why…

Read more »

Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »